Literature DB >> 27909171

Psilocybin for depression and anxiety associated with life-threatening illnesses.

John D McCorvy1, Reid Hj Olsen1, Bryan L Roth2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27909171     DOI: 10.1177/0269881116675771

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


× No keyword cloud information.
  3 in total

Review 1.  The promises and perils of psychedelic pharmacology for psychiatry.

Authors:  Tristan D McClure-Begley; Bryan L Roth
Journal:  Nat Rev Drug Discov       Date:  2022-03-17       Impact factor: 84.694

2.  Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness.

Authors:  William Barone; Michiko Mitsunaga-Whitten; Lia Osunfunláyò Blaustein; Phillip Perl; Marisa Swank; Thomas Cody Swift
Journal:  Front Psychiatry       Date:  2022-09-27       Impact factor: 5.435

3.  Psilocybin and Mental Health-Don't Lose Control.

Authors:  Joseph M Barnby; Mitul A Mehta
Journal:  Front Psychiatry       Date:  2018-07-03       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.